Yasuo Ono
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yasuo Ono has a total of 187 co-authors. Here are the top co-authors by number of shared publications:
Otohiko Kunii
7 shared publications- Takane Kikuchi-Ueda
Department of Microbiology and Immunology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan
5 shared publications - Teruo Akuta
Research and Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna Takahagi-shi, Ibaraki, 318-0004, Japan
5 shared publications - Tsuneyuki Ubagai
Department of Microbiology & Immunology, Teikyo University School of Medicine, Tokyo, Japan
5 shared publications - Yoshinori Sato
Department of Microbiology and Immunology, Teikyo University School of Medicine, Tokyo, Japan
5 shared publications Yukihisa Miyazawa
5 shared publications
Latest Publications
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S234
Gel immersion endoscopy facilitates endoscopic hemostasis of Dieulafoy’s lesions in the small intestine
Aims It is often challenging to treat Dieulafoy’s lesions in the small intestine (Yano-Yamamoto classification Type 2a) due to intermittent and pulsatile bleeding. After spontaneous hemostasis, finding a minute red dot or fibrin plug surrounded by normal mucosa can be challenging. It can be difficult to secure the visual field while performing endoscopic hemostasis of a Dieulafoy’s lesion with active bleeding. The efficacy of gel immersion endoscopy (GIE) during endoscopy for GI bleeding was reported. The efficacy of GIE to treat Dieulafoy’s lesions was retrospectively evaluated. Methods From May 2005 until May 2022, 36 lesions in 34 patients (mean age 71 years, male: 22) were included. Results Of 34 patients, 22 (64%) had a history of multiple examinations or admissions for recurrent obscure GI bleeding. In 14 patients (41%), it took more than 6 months to establish the diagnosis after an initial bleeding episode. Of 36 lesions, 18 were treated using double-balloon enteroscopy with GIE, and 18 were treated with non-GIE (gas insufflation or water immersion). The procedure time to obtain hemostasis and the number of hemo-clips used were compared for the GIE and non-GIE groups. The procedure time was significantly shorter in the GIE group than the non-GIE group (26.7 vs 43.9 minutes, p<0.05). The number of hemo-clips tended to be fewer in the GIE group, although without statistical significance (3.1 vs. 3.3, p=0.36). Conclusions GIE facilitates endoscopic hemostasis of Dieulafoy’s lesions in the small intestine. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S234
Gel immersion endoscopy facilitates endoscopic hemostasis of Dieulafoy’s lesions in the small intestine
Aims It is often challenging to treat Dieulafoy’s lesions in the small intestine (Yano-Yamamoto classification Type 2a) due to intermittent and pulsatile bleeding. After spontaneous hemostasis, finding a minute red dot or fibrin plug surrounded by normal mucosa can be challenging. It can be difficult to secure the visual field while performing endoscopic hemostasis of a Dieulafoy’s lesion with active bleeding. The efficacy of gel immersion endoscopy (GIE) during endoscopy for GI bleeding was reported. The efficacy of GIE to treat Dieulafoy’s lesions was retrospectively evaluated. Methods From May 2005 until May 2022, 36 lesions in 34 patients (mean age 71 years, male: 22) were included. Results Of 34 patients, 22 (64%) had a history of multiple examinations or admissions for recurrent obscure GI bleeding. In 14 patients (41%), it took more than 6 months to establish the diagnosis after an initial bleeding episode. Of 36 lesions, 18 were treated using double-balloon enteroscopy with GIE, and 18 were treated with non-GIE (gas insufflation or water immersion). The procedure time to obtain hemostasis and the number of hemo-clips used were compared for the GIE and non-GIE groups. The procedure time was significantly shorter in the GIE group than the non-GIE group (26.7 vs 43.9 minutes, p<0.05). The number of hemo-clips tended to be fewer in the GIE group, although without statistical significance (3.1 vs. 3.3, p=0.36). Conclusions GIE facilitates endoscopic hemostasis of Dieulafoy’s lesions in the small intestine. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 1 June 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 3357-3368
Tigecycline Suppresses the Virulence Factors of Multidrug-Resistant Acinetobacter baumannii Allowing Human Neutrophils to Act
Purpose: To determine the ability of human neutrophils to kill multidrug-resistant Acinetobacter baumannii (MDRAB) in the presence of tigecycline (TGC). Methods: Clinical isolates of MDRAB were cultured with human neutrophils and H2O2 in the presence of TGC. The numbers of viable bacteria, catalase activity, gene expression at the K locus of the MDRAB, reactive oxygen species (ROS) production, and granule exocytosis in human neutrophils were determined. Results: There was a time-dependent increase in the numbers of MDRAB after co-culturing with human neutrophils, whereas there was a significant decrease in the MDRAB numbers when co-cultured with both, human neutrophils and TGC for 6 h. The presence or absence of TGC did not affect total ROS production or the expression of CD11b, CD15, and CD63 on human neutrophils occurred when co-cultured with MDRAB. TGC significantly suppressed catalase activity and gene expression at the K locus of MDRAB, and significantly reduced the thickness of the capsule. Additionally, the bacterial viability of TGC-treated MDRAB cultured with H2O2 was lower than that without H2O2 after 6 h of culture. Conclusion: TGC significantly suppressed the expression of catalase and the capsule in MDRAB without adverse effects on neutrophil function, allowing human neutrophils to kill MDRAB. TGC is an effective antibiotic for treating MDRAB infections.
- 1 June 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 3357-3368
Open AccessTigecycline Suppresses the Virulence Factors of Multidrug-Resistant Acinetobacter baumannii Allowing Human Neutrophils to Act
Purpose: To determine the ability of human neutrophils to kill multidrug-resistant Acinetobacter baumannii (MDRAB) in the presence of tigecycline (TGC). Methods: Clinical isolates of MDRAB were cultured with human neutrophils and H2O2 in the presence of TGC. The numbers of viable bacteria, catalase activity, gene expression at the K locus of the MDRAB, reactive oxygen species (ROS) production, and granule exocytosis in human neutrophils were determined. Results: There was a time-dependent increase in the numbers of MDRAB after co-culturing with human neutrophils, whereas there was a significant decrease in the MDRAB numbers when co-cultured with both, human neutrophils and TGC for 6 h. The presence or absence of TGC did not affect total ROS production or the expression of CD11b, CD15, and CD63 on human neutrophils occurred when co-cultured with MDRAB. TGC significantly suppressed catalase activity and gene expression at the K locus of MDRAB, and significantly reduced the thickness of the capsule. Additionally, the bacterial viability of TGC-treated MDRAB cultured with H2O2 was lower than that without H2O2 after 6 h of culture. Conclusion: TGC significantly suppressed the expression of catalase and the capsule in MDRAB without adverse effects on neutrophil function, allowing human neutrophils to kill MDRAB. TGC is an effective antibiotic for treating MDRAB infections.
- Open Access
- 19 March 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Development of a rapid scabies immunodiagnostic assay based on transcriptomic analysis of Sarcoptes scabiei var. nyctereutis
Scabies is a highly contagious skin disease caused by the mite Sarcoptes scabiei that affects many mammals. However, the sensitivity of traditional tests for scabies diagnosis in humans is less than 50%. To simplify the diagnosis of scabies, methods that are simple, sensitive, specific, and cost-effective are required. We developed an immunodiagnostic test based on S. scabiei var. nyctereutis RNA-seq data collected from Japanese raccoon dogs with sarcoptic mange. Three candidate antigens—a highly expressed hypothetical protein “QR98_0091190,” another mite allergen known as “SMIPP-Cc,” and an abundant “vitellogenin-like protein”—were evaluated by western-blot analysis. A lateral flow immunoassay, using specific antibodies against the vitellogenin-like protein, successfully detected scabies in the skin flakes of S. scabiei-infected raccoon dogs. This assay can potentially diagnose scabies more accurately in wildlife, as well as in humans.
- 19 March 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Open AccessDevelopment of a rapid scabies immunodiagnostic assay based on transcriptomic analysis of Sarcoptes scabiei var. nyctereutis
Scabies is a highly contagious skin disease caused by the mite Sarcoptes scabiei that affects many mammals. However, the sensitivity of traditional tests for scabies diagnosis in humans is less than 50%. To simplify the diagnosis of scabies, methods that are simple, sensitive, specific, and cost-effective are required. We developed an immunodiagnostic test based on S. scabiei var. nyctereutis RNA-seq data collected from Japanese raccoon dogs with sarcoptic mange. Three candidate antigens—a highly expressed hypothetical protein “QR98_0091190,” another mite allergen known as “SMIPP-Cc,” and an abundant “vitellogenin-like protein”—were evaluated by western-blot analysis. A lateral flow immunoassay, using specific antibodies against the vitellogenin-like protein, successfully detected scabies in the skin flakes of S. scabiei-infected raccoon dogs. This assay can potentially diagnose scabies more accurately in wildlife, as well as in humans.
- Open Access
Acinetobacter baumannii LOS Regulate the Expression of Inflammatory Cytokine Genes and Proteins in Human Mast Cells
Herein, we investigated the effect of bacterial lipooligosaccharides (LOS), from Acinetobacter baumannii, on the expression of pro-inflammatory genes that play an essential role in bacterial clearance. LAD2 human mast cells were stimulated with LOS derived from two strains of A. baumannii—ATCC 19606 and MDRA T14. LOS exposure induced the expression of genes for pro-inflammatory mediators, including TNF-α, IL-8, LTC4S, CCL4, and TLR4. The mRNA expression levels of a majority of the pro-inflammatory genes, except TLR4, in A. baumannii-LOS stimulated mast cells were increased. Moreover, co-culture of neutrophils with the supernatant obtained from LOS (ATCC 19606 and MDRA T14)-induced LAD2 cells increased the transmigration of neutrophils, which plays a critical role in the early protection against bacterial infections. The results of the present study suggest that LOS could be involved in the pathogenicity of A. baumannii by inducing inflammatory responses via mast cells and that IL-8 is involved in recruiting neutrophils in response to bacterial invasion.
Open AccessAcinetobacter baumannii LOS Regulate the Expression of Inflammatory Cytokine Genes and Proteins in Human Mast Cells
Herein, we investigated the effect of bacterial lipooligosaccharides (LOS), from Acinetobacter baumannii, on the expression of pro-inflammatory genes that play an essential role in bacterial clearance. LAD2 human mast cells were stimulated with LOS derived from two strains of A. baumannii—ATCC 19606 and MDRA T14. LOS exposure induced the expression of genes for pro-inflammatory mediators, including TNF-α, IL-8, LTC4S, CCL4, and TLR4. The mRNA expression levels of a majority of the pro-inflammatory genes, except TLR4, in A. baumannii-LOS stimulated mast cells were increased. Moreover, co-culture of neutrophils with the supernatant obtained from LOS (ATCC 19606 and MDRA T14)-induced LAD2 cells increased the transmigration of neutrophils, which plays a critical role in the early protection against bacterial infections. The results of the present study suggest that LOS could be involved in the pathogenicity of A. baumannii by inducing inflammatory responses via mast cells and that IL-8 is involved in recruiting neutrophils in response to bacterial invasion.
- Open Access
- 18 November 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (11) , 1816
Emergence of Enterobacter cloacae Complex Co-Producing IMP-10 and CTX-M, and Klebsiella pneumoniae Producing VIM-1 in Clinical Isolates in Japan
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat in healthcare settings worldwide. Objectives: We evaluated the presence of carbapenemase genes in CPE in a tertiary care university hospital in Tokyo, Japan. Methods: Carbapenem-resistant clinical isolates were collected in 2018 at Teikyo University Hospital (Tokyo, Japan). Bacterial species were identified using MALDI-TOF MS. Carbapenemase production was evaluated using a carbapenemase inactivation method. The presence of carbapenemase genes was confirmed by multiplex PCR and DNA sequencing. Results: Four CPE isolates were identified: two Enterobacter cloacae complex strains and Klebsiella oxytoca and Klebsiella pneumoniae strains. Three of the isolates (E. cloacae complex and K. oxytoca) were IMP-1-type producers, including IMP-10 in their produced metallo-β-lactamase, and are epidemic in East Japan. The IMP-10-producing E. cloacae complex strain also produced CTX-M ESBL. The other CPE isolate (K. pneumoniae) is a VIM-1 producer. VIM-1-producing K. pneumoniae is epidemic in Europe, especially in Greece. Accordingly, the VIM-1 producer was isolated from a patient with a medical history in Greece. Conclusions: This study revealed the emergence of E. cloacae complex co-producing IMP-1-type carbapenemase and CTX-M ESBL, and K. pneumoniae producing VIM-1 carbapenemase in clinical isolates in Japan. Metallo-β-lactamase was the most prevalent type of carbapenemase at Teikyo University Hospital, especially IMP-1-type carbapenemase. The detection of VIM-1-producing K. pneumoniae suggests that epidemic CPE from overseas can spread to countries with low CPE prevalence, such as Japan, highlighting the need for active surveillance.
- 18 November 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (11) , 1816
Open AccessEmergence of Enterobacter cloacae Complex Co-Producing IMP-10 and CTX-M, and Klebsiella pneumoniae Producing VIM-1 in Clinical Isolates in Japan
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat in healthcare settings worldwide. Objectives: We evaluated the presence of carbapenemase genes in CPE in a tertiary care university hospital in Tokyo, Japan. Methods: Carbapenem-resistant clinical isolates were collected in 2018 at Teikyo University Hospital (Tokyo, Japan). Bacterial species were identified using MALDI-TOF MS. Carbapenemase production was evaluated using a carbapenemase inactivation method. The presence of carbapenemase genes was confirmed by multiplex PCR and DNA sequencing. Results: Four CPE isolates were identified: two Enterobacter cloacae complex strains and Klebsiella oxytoca and Klebsiella pneumoniae strains. Three of the isolates (E. cloacae complex and K. oxytoca) were IMP-1-type producers, including IMP-10 in their produced metallo-β-lactamase, and are epidemic in East Japan. The IMP-10-producing E. cloacae complex strain also produced CTX-M ESBL. The other CPE isolate (K. pneumoniae) is a VIM-1 producer. VIM-1-producing K. pneumoniae is epidemic in Europe, especially in Greece. Accordingly, the VIM-1 producer was isolated from a patient with a medical history in Greece. Conclusions: This study revealed the emergence of E. cloacae complex co-producing IMP-1-type carbapenemase and CTX-M ESBL, and K. pneumoniae producing VIM-1 carbapenemase in clinical isolates in Japan. Metallo-β-lactamase was the most prevalent type of carbapenemase at Teikyo University Hospital, especially IMP-1-type carbapenemase. The detection of VIM-1-producing K. pneumoniae suggests that epidemic CPE from overseas can spread to countries with low CPE prevalence, such as Japan, highlighting the need for active surveillance.
- Open Access
- 18 March 2020
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 113 (9) , 679-680
Kawasaki disease caused by Yersinia pseudotuberculosis infection
- 18 March 2020
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 113 (9) , 679-680
Open AccessKawasaki disease caused by Yersinia pseudotuberculosis infection
- Open Access
- 1 January 2020
- Published by Japanese Society for Bacteriology in Nippon Saikingaku Zasshi
- Vol. 75 (1) , 36-59
Workshop
- 1 January 2020
- Published by Japanese Society for Bacteriology in Nippon Saikingaku Zasshi
- Vol. 75 (1) , 36-59
Open AccessWorkshop
- Open Access
- 1 January 2020
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 40 (1) , 27-32
A Novel Mismatched PCR-Restriction Fragment Length Polymorphism Assay for Rapid Detection of gyrA and parC Mutations Associated With Fluoroquinolone Resistance in Acinetobacter baumannii
Kakuta N, et al. Ann Lab Med. 2020 Jan;40(1):27-32. https://doi.org/10.3343/alm.2020.40.1.27
- 1 January 2020
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 40 (1) , 27-32
Open AccessA Novel Mismatched PCR-Restriction Fragment Length Polymorphism Assay for Rapid Detection of gyrA and parC Mutations Associated With Fluoroquinolone Resistance in Acinetobacter baumannii
Kakuta N, et al. Ann Lab Med. 2020 Jan;40(1):27-32. https://doi.org/10.3343/alm.2020.40.1.27